NSAID-exacerbated respiratory disease, dupilumab and aspirin tolerance

EUROPEAN RESPIRATORY JOURNAL（2023）

引用 0|浏览13

暂无评分

摘要

Shareable abstract (@ERSpublications) Schneider et al. add to the growing evidence that dupilumab is very effective in N-ERD inducing increased tolerance to ASA in 57% of patients (complete in 23%), accompanied by improvements in both upper and lower airway clinical features of disease https://bit.ly/3jqs1DC

查看译文

关键词

aspirin tolerance,respiratory disease,dupilumab,nsaid-exacerbated

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要